The pharmaceutical landscape in this country is increasingly characterized by a pattern toward market dominance, with a handful of prominent companies wielding significant control. These industry giants, often bolstered by extensive distribution networks and robust brand recognition, present a complex picture for competition and accessible healthca

India has emerged as a global powerhouse in the pharmaceutical sector, renowned for its affordable medications and robust manufacturing capabilities. However, beneath the surface of this success lies a complex landscape marked by concerns regarding monopolies and market dominance. A handful of large pharmaceutical companies have established signifi